For Faculty

At The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), our nationally and internationally recognized multidisciplinary team of specialists, sub-specialists, researchers, scientists and educators combine their collective expertise to lead the nation in transforming oncology education, training and research.

Cancer is complex, and today, it is no longer solely defined by location or even by stage. That’s why finding and delivering the most effective new strategies for cancer prevention, detection, diagnosis and treatment all begin with one of the world’s top CCCs, the experts inside and the education and training they provide.

The OSUCCC – James offers faculty members the unique advantage of highly collaborative programs at a well-respected campus university where world-recognized cancer research labs with internationally recognized scientists, researchers and faculty members are within a five-minute walk to The James Cancer Hospital, one of the leading cancer centers in the country.

Click on the links below for more program information.

Davis Bremer

The Davis Bremer Pre-K Program supports the career development of tenure and clinical track faculty in the College of Medicine who have an MD degree and who have made a commitment to conduct either patient-oriented or translational research.

Read More

FAME

The Faculty Advancement, Mentoring and Engagement (FAME) program offers a wealth of mentoring opportunities, competency-based instruction and recognition programs that foster professional fulfillment and growth.

Read More

The Ohio State University Comprehensive Cancer Center (OSUCCC) is a network of five interdisciplinary, cancer-related research programs

These programs collectively comprise more than 300 highly trained researchers and scientists representing 11 of the 15 colleges at Ohio State – all with the shared goal to understand what makes each patient’s cancer grow, spread or reoccur by utilizing basic, clinical, prevention and population research that translates to innovative, leading-edge care and cancer-prevention strategies.

The OSUCCC is one of only 51 CCCs in the nation as designated by the National Cancer Institute (NCI). The designation was most recently renewed in 2015, when NCI rated Ohio State’s cancer program as Exceptional, the highest descriptor.

Additionally, the OSUCCC – James is one of only a handful of U.S. cancer centers that is NCI-funded to conduct phase I and phase II clinical trials. These trials go only to centers that demonstrate an exemplary capacity for research and clinical care, the expertise to deliver the latest treatments, and the infrastructure to interpret and track results.

Because of these phase I and phase II approvals, the OSUCCC - James experts can move research discoveries into clinical trials faster and get them to patients sooner.

Contact Us

Kellee Gauthier, MPH
Admin Director, CAMELOT


614-293-9947
Email Kellee

Lawrence Kirschner, MD, PhD

CAMELOT Director


Lawrence Kirschner

 

Dr. Kirschner is a physician-scientist and clinical endocrinologist who specializes in treating patients with pituitary and adrenal tumors. He is also the director of the CAMELOT Program and a member of the Cancer Biology Program at the OSUCCC – James.

Learn More

Kellee Gauthier, MPH

CAMELOT Admin Director


Kellee Gauthier

Kellee directs, manages and oversees the administrative, programmatic and operational activities of CAMELOT, working closely with CCC leadership to provide strategic leadership.